Close

Biogen (BIIB) Surges After 'Best-Case' Alzheimer's Drug Trial Results; Stock Earns Several Upgrades

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. ENPH
3. TXN
4. META
5. BA
6. SPOT
7. IBM
8. V
9. KMB
10. HCP


Go back to Biogen (BIIB) Surges After 'Best-Case' Alzheimer's Drug Trial Results; Stock Earns Several Upgrades
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 201.99 +8.81 (4.56%)
Previous Close $193.18    52 Week High $333.65 
Open $198.97    52 Week Low $223.02 
Day High $205.75    P/E 25.86 
Day Low $198.97    EPS $7.81 
Volume 3,265,656